Dr. Roy L. Foliente, MD

Dr. Foliente practices at MountainView Regional Medical Center in Las Cruces, New Mexico, part of Community Health Systems.

Dr. Foliente's NPI, 1598723348, was assigned on May 2, 2006. Dr. Foliente graduated from Loma Linda University School Of Medicine in 1993. Dr. Foliente holds California license G81098.

Dr. Foliente's primary practice is MountainView Regional Medical Center, at 4311 East Lohman Avenue, Las Cruces, NM 88011 in Dona Ana County. The practice phone is (575) 556-7610.

Dr. Foliente's primary practice is MountainView Regional Medical Center in Las Cruces, New Mexico, part of Community Health Systems. The medical group on file is MountainView Medical Group. Dmand AI also links Dr. Foliente to 3 more medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Foliente practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Foliente's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Foliente is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Foliente's licenses on file in 3 states: California, New Mexico and Hawaii.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Foliente treats.

CMS data shows 262 Medicare services from Dr. Foliente across 7 procedure codes in 2024, for 183 Medicare patients. Medicare paid $23,696 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 183 Medicare patients who saw Dr. Foliente in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Foliente's median patient age at 69, with 54% women.

In 2024, Dr. Foliente wrote 730 Medicare Part D claims for 328 patients. 93% of them were for generic drugs. CMS names the drug for 617 of them, across 9 drugs with 11 or more claims each, at $14,651 in total drug cost. In 2023, CMS named 1,431 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Foliente for performance year 2024, reported as part of a group. Dr. Foliente accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 116 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Foliente, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Foliente. The most frequent topics are Colorectal Neoplasms, Occult Blood and Pancreatitis. Dr. Foliente has published most often in Am J Gastroenterol. Dr. Foliente's most frequent co-authors are John Daniel Abdulian, MD and Michael H. Walter, MD.

CMS Open Payments shows 56 general payments to Dr. Foliente from 16 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $609.

Dmand AI lists 2 awards for Dr. Foliente, most recently AGA Fellow in 2011.

Dr. Foliente graduated from Loma Linda University School Of Medicine in 1993. Dr. Foliente is a member of ACP and AGA.

Dr. Foliente is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.